HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey B Travers Selected Research

platelet activating factor receptor

2/2022Acute ethanol exposure stimulates microvesicle particle generation in keratinocytes.
1/2022UVB-Induced Microvesicle Particle Release and Its Effects on the Cutaneous Microenvironment.
11/2020Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells.
1/2015Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
1/2014Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin.
1/2014Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis.
1/2014Platelet-Activating Factor-Receptor and Tumor Immunity.
3/2012Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.
3/2012Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.
10/2005Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey B Travers Research Topics

Disease

26Neoplasms (Cancer)
01/2022 - 12/2003
16Inflammation (Inflammations)
04/2018 - 01/2002
15Atopic Dermatitis (Atopic Eczema)
06/2022 - 01/2002
13Skin Neoplasms (Skin Cancer)
11/2021 - 03/2009
11Melanoma (Melanoma, Malignant)
01/2022 - 06/2012
7Carcinogenesis
11/2021 - 03/2012
6Skin Diseases (Skin Disease)
11/2017 - 02/2003
5Psoriasis (Pustulosis Palmaris et Plantaris)
04/2021 - 01/2002
5Contact Dermatitis (Eczema, Contact)
01/2018 - 07/2008
4Burns
02/2022 - 10/2018
3Asthma (Bronchial Asthma)
06/2022 - 12/2010
3Actinic Keratosis
10/2021 - 01/2020
3Infections
04/2021 - 09/2003
3Eczema
09/2013 - 01/2010
2Alopecia Areata
06/2022 - 04/2022
2Pathologic Processes
12/2021 - 01/2021
2COVID-19
04/2021 - 01/2021
2Wounds and Injuries (Trauma)
05/2019 - 10/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2016 - 07/2013
2Basal Cell Nevus Syndrome (Gorlin Syndrome)
04/2015 - 09/2014
2Neoplasm Metastasis (Metastasis)
01/2015 - 01/2014
2Stevens-Johnson Syndrome (Lyell's Syndrome)
06/2011 - 12/2004
2Hypersensitivity (Allergy)
07/2008 - 10/2005
2Carcinoma (Carcinomatosis)
05/2004 - 05/2003
1Alopecia (Baldness)
06/2022
1Rhinosinusitis
06/2022
1Keloid
06/2022
1Hypopigmentation (Hypomelanosis)
06/2022
1Atrophy
06/2022
1Cicatrix (Scar)
06/2022
1Hypoxia (Hypoxemia)
09/2021
1Angioedema
06/2021
1Hereditary Angioedemas
06/2021
1Vitamin D Deficiency
04/2021
1Rheumatoid Arthritis
04/2021
1Rickets (Rachitis)
04/2021
1Tuberculosis (Tuberculoses)
04/2021
1Lung Neoplasms (Lung Cancer)
11/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020
1Pressure Ulcer (Bedsore)
05/2019

Drug/Important Bio-Agent (IBA)

16CytokinesIBA
12/2021 - 01/2002
14Platelet Activating FactorIBA
01/2021 - 05/2003
12platelet activating factor receptorIBA
02/2022 - 05/2003
11LipidsIBA
01/2021 - 05/2003
7Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2003
6AntioxidantsIBA
01/2015 - 04/2003
5Insulin-Like Growth Factor I (IGF-1)IBA
11/2021 - 09/2016
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2011
4CarcinogensIBA
01/2021 - 07/2008
41-O-hexadecyl-2-N-methylcarbamol -sn-glycerol-3-phosphocholineIBA
01/2015 - 10/2005
3Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022 - 01/2014
3AntigensIBA
10/2021 - 03/2012
3Vitamin DFDA LinkGeneric
04/2021 - 09/2013
3STAT6 Transcription FactorIBA
04/2018 - 01/2012
3Immunoglobulin E (IgE)IBA
01/2016 - 01/2002
3Phorbol EstersIBA
01/2014 - 04/2003
3Interleukin-4 (Interleukin 4)IBA
11/2013 - 01/2002
3DinitrofluorobenzeneIBA
03/2012 - 10/2005
2Pharmaceutical PreparationsIBA
06/2022 - 12/2012
2dupilumabIBA
06/2022 - 04/2022
2GlycosaminoglycansIBA
06/2022 - 07/2002
2Ethanol (Ethyl Alcohol)IBA
02/2022 - 11/2018
2Interleukin-8 (Interleukin 8)IBA
12/2021 - 09/2003
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2016 - 12/2014
2HhAntag691IBA
04/2015 - 09/2014
2SmokeIBA
01/2014 - 03/2013
2Messenger RNA (mRNA)IBA
12/2011 - 01/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2011 - 09/2003
2lipoteichoic acidIBA
01/2010 - 10/2005
2ChemokinesIBA
02/2003 - 07/2002
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
06/2022
1CollagenIBA
06/2022
1Insulin-Like PeptidesIBA
10/2021
1VaccinesIBA
10/2021
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
10/2021
1Aminolevulinic Acid (Levulan)FDA Link
09/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2021
1Oral ContraceptivesIBA
06/2021
1Estrogens (Estrogen)FDA Link
06/2021
125-hydroxyvitamin DIBA
04/2021
1Calcitriol (Calcijex)FDA LinkGeneric
04/2021
1hydroxide ionIBA
04/2021
1GTP-Binding Proteins (G-Protein)IBA
11/2020
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2020
1Gefitinib (Iressa)FDA Link
11/2020
1Immunologic Factors (Immunomodulators)IBA
10/2019

Therapy/Procedure

7Therapeutics
10/2021 - 04/2011
6Drug Therapy (Chemotherapy)
01/2022 - 05/2003
4Lasers (Laser)
10/2021 - 06/2012
2Immunotherapy
10/2021 - 12/2011
1Intralesional Injections
06/2022
1Aftercare (After-Treatment)
06/2022
1Injections
06/2022
1Heterologous Transplantation (Xenotransplantation)
10/2021
1Photochemotherapy (Photodynamic Therapy)
09/2021
1Phototherapy (Light Therapy)
04/2021
1Percutaneous Collagen Induction
01/2020